Improving drug adherence among patients with heart disease using mobile health and community heath worker led interventio
Phase 3
- Conditions
- Health Condition 1: I25- Chronic ischemic heart disease
- Registration Number
- CTRI/2023/10/059095
- Lead Sponsor
- World Health Organization, Geneva
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed cases of CAD encompassing all cases admitted and who received treatment for a MI/NSTEMI/UA (Fourth Universal definition of myocardial Infarction 2018) or have the disease as diagnosed from a coronary angiogram or CT coronary angiogram or have undergone a re-vascularization procedure for the same from the updated ENDIRA cohort list in 2019
Exclusion Criteria
Pregnant or lactating mothers, non-consenting individuals, presence of other significant comorbidities like dementia, stroke, cancers, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in medication adherence score by 0.4 unit with Morisky Medication Adherence Scale 8Timepoint: After 3 months of intervention followed by another 5 months of intervention
- Secondary Outcome Measures
Name Time Method Incremental Cost Effective RatioTimepoint: After 8 months of intervention;Quality of LifeTimepoint: After 3 months of intervention followed by another 5 months of intervention